Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions are supporting biopharma companies around the world to develop and produce drugs safely, timely and economically. To meet the rapidly changing technology requirements of the industry it serves, Sartorius Stedim Biotech focuses on single-use technologies and value-added services.
In 2014 TAP Biosystems became a part of the Sartorius Stedim Biotech Group.
TAP Biosystems is a leading global provider of automated cell culture and fermentation systems to the bio-pharma, regenerative medicine and industrial biotechnology sectors, focusing on:
- Bioprocess development
- Cell therapy & stem cell research
- GMP manufacture of biologics
- Discovery research